000			02378 a2200721 4500
005			20250514183805.0
264		0	_c20050302
008			200503s 0 0 eng d
022			_a0268-3369
024	7		_a10.1038/sj.bmt.1704493 _2doi
040			_aNLM _beng _cNLM
100	1		_aRodriguez, R
245	0	0	_aCyclosporine and mycophenolate mofetil prophylaxis with fludarabine and melphalan conditioning for unrelated donor transplantation: a prospective study of 22 patients with hematologic malignancies. _h[electronic resource]
260			_bBone marrow transplantation _cJun 2004
300			_a1123-9 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aCyclosporine _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aGraft Survival
650	0	4	_aGraft vs Host Disease _xprevention & control
650	0	4	_aHematologic Neoplasms _xcomplications
650	0	4	_aHematopoietic Stem Cell Transplantation _xadverse effects
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMelphalan _xadministration & dosage
650	0	4	_aMiddle Aged
650	0	4	_aMycophenolic Acid _xadministration & dosage
650	0	4	_aOpportunistic Infections
650	0	4	_aPremedication _xmethods
650	0	4	_aProspective Studies
650	0	4	_aSurvival Analysis
650	0	4	_aTissue Donors
650	0	4	_aTransplantation Conditioning _xmethods
650	0	4	_aTreatment Outcome
650	0	4	_aVidarabine _xadministration & dosage
700	1		_aParker, P
700	1		_aNademanee, A
700	1		_aSmith, D
700	1		_aO'Donnell, M R
700	1		_aStein, A
700	1		_aSnyder, D S
700	1		_aFung, H C
700	1		_aKrishnan, A Y
700	1		_aPopplewell, L
700	1		_aCohen, S
700	1		_aSomlo, G
700	1		_aAngelopoulou, M
700	1		_aAl-Kadhimi, Z
700	1		_aFalk, P M
700	1		_aSpielberger, R
700	1		_aKogut, N
700	1		_aSahebi, F
700	1		_aSenitzer, D
700	1		_aSlovak, M
700	1		_aSchriber, J
700	1		_aForman, S J
773	0		_tBone marrow transplantation _gvol. 33 _gno. 11 _gp. 1123-9
856	4	0	_uhttps://doi.org/10.1038/sj.bmt.1704493 _zAvailable from publisher's website
999			_c14780332 _d14780332